36 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday.
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter.
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first two sessions of the holiday-shortened week before making a comeback.
Endo Reaches Agreement Intended To Settle Florida Governmental Opioid Cases And Claims For $65M
Endo International plc (NASDAQ:ENDP) ("Endo") today announced that it and its wholly-owned subsidiaries Endo Pharmaceuticals Inc. and Endo Health Solutions Inc. have entered into a statewide settlement
Endo Int’l. Reports Deal Intended To Settle Texas Governmental Opioid Cases, Claims; Payment Would Be $63M
Endo International plc (NASDAQ:ENDP) ("Endo") today announced that it and its wholly-owned subsidiaries Endo Pharmaceuticals Inc., Endo Health Solutions Inc., Par Pharmaceutical, Inc., and Par Pharmaceutical
Endo Int’l. Reports Deal With Paladin Labs To Commercialize SK Biopharma’s XCOPRI In Canada, No Terms Disclosed
Endo International plc (NASDAQ:ENDP) announced today that its subsidiary Endo Ventures Limited has entered into definitive agreements with SK Biopharmaceuticals for the development, registration, supply,
58 Biggest Movers From Yesterday
Gainers
Adagio Therapeutics, Inc. (NASDAQ: ADGI) shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price target from Jefferies.
Endo Announces Favorable Final Ruling In California State Court Opioid Trial
Endo International plc (NASDAQ:ENDP) ("Endo") today announced that one of the first public nuisance cases filed against manufacturers of prescription opioid medications has ended with a California trial court issuing a final ruling that the defendants, including Endo's wholly-owned subsidiaries Endo Healt
Endo Issues ‘Public Statement Against Use of Medicines for Capital Punishment’
At Endo, our vision is to help everyone we serve live their best life. To achieve that vision, every day our global team members are focused on the development and delivery of life-enhancing products. For over 50 years,